[ad_1]
The shares of Lowe's Companies, Inc. (NYSE: LOW) have grown more than 6.00% this year and have recently decreased by -0.50% or -0.5% for S & # Set to $ 98.52. In contrast, Actinium Pharmaceuticals, Inc. (NYSE: ATNM) is up 13.85% since 26/07/2018. It is currently trading at $ 0.76 and has returned -0.85% over the last week.
Lowe's Companies, Inc. (NYSE: LOW) and Actinium Pharmaceuticals, Inc. (NYSE: ATNM) are the two most active stocks in the Home Improvement Store industry based on trading volumes of # 39; aujourd & # 39; hui. The market is clearly enthusiastic about these two actions, but what is the best investment? To answer this question, we will compare the two companies based on the strength of their growth, profitability, risk, returns, valuation, badyst recommendations and internal trends.
Growth
rate is a defining characteristic of the best companies for long-term investment. Analysts expect LOW to grow at an annual rate of 16.00% over the next 5 years.
Profitability and Returns
Growth does not attract investors if companies sacrifice profitability and shareholder profits. We will use the EBITDA margin and return on investment (ROI), which control the differences in capital structure between the two companies, to measure profitability and performance. Lowe's Companies, Inc. (LOW) has an EBITDA margin of 10.7%. This suggests that the underlying activities are more profitable
Cash Flow
Profits do not always accurately reflect the amount of cash that a company reports. Free cash flow ("FCF") per share for the last twelve months was +3.47. Comparatively, free cash flow per share of TNTA was -0.06
Liquidity and Financial Risk
The liquidity and leverage ratios are important as they reveal the financial health of a corporation. business. LOW has a current ratio of 1.00 compared to 4.30 for ATNM. This means that ATNM can more easily cover its most immediate liabilities over the next twelve months. The debt ratio of LOW is 2.76 against a D / E of 0.00 for NNTA. LOW is therefore the most solvent of the two companies and has a lower financial risk.
Valuation
LOW traded at a forward P / E of 16.10, a P / B of 14.16, and a P / S of 1.17, compared to a P / B of 3.02 , for ATNM. LOW is the highest price of both shares in terms of earnings, book value and sales. Since profits are the most important for investors, badysts tend to put more weight on the price / earnings ratio.
Targets and opinions of badysts
There is more value to have. In order to evaluate the value, we must compare the current price to where it is likely to be traded in the future. The LOW price is currently -9.24% to its goal of 108.55. Comparatively, ATNM is -82.28% compared to its goal of 4.29. This suggests that the ATNM is the best investment during the following year
Risk and Volatility
Beta is a metric that investors frequently use to badyze systematic risk of an action. A beta greater than 1 implies a volatility higher than the market average. Conversely, a security with a beta lower than 1 is considered less risky than the overall market. LOW has a beta of 1.33 and the beta of ATNM is 2.15. LOW shares are therefore the least volatile of the two shares
Insider activity and investor sentiment
The short-term interest is another tool that badysts use to evaluate the sentiment of investors . It represents the percentage of marketable shares of an action that are subject to a short circuit. LOW has a short ratio of 1.73 compared to a short interest of 2.34 for ATNM. This implies that the market is currently less bearish on the prospects of LOW
Abstract
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) beats Lowe's Companies, Inc. (NYSE: LOW) out of a total of 7 13 factors compared between the two stocks. ATNM is growing rapidly and presents a lower financial risk. In terms of valuation, ATNM is the least expensive of the two values in terms of profit, book value and turnover, with ATNM being more undervalued compared to its target price. Finally, HMY has better sentiment signals based on a short interest.
Source link
